Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses

Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses

Bibliographic Details
Main Authors:	Freel, SA, Picking, R, Ferrari, G, Ochsenbauer, C, Kappes, J, Kirchherr, J, Weinhold, K, Soderberg, K, Mcmichael, A, Haynes, B, Tomaras, G
Format:	Conference item
Published:	2011

Similar Items

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
by: Freel, SA, et al.
Published: (2012)

Phenotypic properties of transmitted founder HIV-1.
by: Parrish, N, et al.
Published: (2013)

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.
by: Goonetilleke, N, et al.
Published: (2009)

Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells.
by: Daniel O Ochiel, et al.
Published: (2010-12-01)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
by: Nathanael P McCurley, et al.
Published: (2017-01-01)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
by: Fouda GG, et al.
Published: (2012-09-01)

HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo.
by: Melanie Merbah, et al.
Published: (2012-01-01)

Phagocytic uptake of transmitted/founder virus-infected CD4+T cells enhances macrophage infection
by: Duncan, C, et al.
Published: (2012)

Resistance of transmitted founder HIV-1 to IFITM-mediated restriction
by: Foster, T, et al.
Published: (2016)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
by: A. Bauer, et al.
Published: (2019-12-01)

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection
by: McMichael A, et al.
Published: (2009-10-01)

Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
by: Fenton-May, A, et al.
Published: (2013)

Implications of viral transmitted/founder (T/F) dynamics on vaccine development
by: Alexander I. Mosa
Published: (2021-07-01)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
by: Nina Hertoghs, et al.
Published: (2019-01-01)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
by: Fouda G, et al.
Published: (2012-09-01)

Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
by: Song, H, et al.
Published: (2014)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
by: Jesus F. Salazar-Gonzalez, et al.
Published: (2016-07-01)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
by: David R. Martinez, et al.
Published: (2020-04-01)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
by: Neeti Ananthaswamy, et al.
Published: (2019-02-01)

ON THE ONTOGENY OF REFERENCE
by: Plunkett, K
Published: (1986)

Autologous or heterologous fibrin sealant scaffold: which is the better choice?
by: Rui Seabra Ferreira
Published: (2014-09-01)

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
by: Nicholas F Parrish, et al.
Published: (2012-01-01)

HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses
by: Evelyn Ngwa Lumngwena, et al.
Published: (2020-07-01)

Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
by: Bernadien M. Nijmeijer, et al.
Published: (2019-07-01)

Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
by: Sheila N. Balinda, et al.
Published: (2022-02-01)

Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants
by: Agano Kiravu, et al.
Published: (2019-10-01)

Ontogeny
by: Nasser Suleiman Gabryel
Published: (2015-06-01)

A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
by: Swati Jain, et al.
Published: (2024-04-01)

Cephalopod ontogeny and life cycle patterns
by: Erica A. G. Vidal, et al.
Published: (2023-07-01)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
by: Borrow, P, et al.
Published: (2019)

A deeper view of transmitted/founder viruses using 454 whole genome deep sequencing
by: Tully DC, et al.
Published: (2012-09-01)

The Ontogeny of Monocyte Subsets
by: Anja A. Wolf, et al.
Published: (2019-07-01)

PP 7.13 – 00090 Early evolution of HIV-1 from transmitted founders during acute infection
by: V. Boltz, et al.
Published: (2022-12-01)

Autologous and Heterologous Minor and Major Bone Regeneration with Platelet-Derived Growth Factors
by: Gianna Dipalma, et al.
Published: (2025-01-01)

The epistemological glaucoma and psematical paradox (autological feature of truth and heterological feature of false)
by: A N Pavlenko
Published: (2018-12-01)

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.
by: Sarah Welbourn, et al.
Published: (2022-05-01)

Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice.
by: Morgan L Chateau, et al.
Published: (2013-01-01)

Floral structure and ontogeny of Syndiclis (Lauraceae).
by: Gang Zeng, et al.
Published: (2017-01-01)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
by: Amit Kumar, et al.
Published: (2018-04-01)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
by: Rachel M. Podgorski, et al.
Published: (2023-08-01)